Dysregulated Expression and Methylation Analysis Identified TLX1NB as a Novel Recurrence Marker in Low-Grade Gliomas
Low-grade gliomas (LGGs) are the most common CNS tumors, and the main therapy for LGGs is complete surgical resection, due to its curative effect. However, LGG recurrence occurs frequently. Biomarkers play a crucial role in evaluating the recurrence and prognosis of LGGs. Numerous studies have focus...
Saved in:
Main Authors: | Hongzhou Duan, Zuozhen Yang, Chen Li, Jiayong Zhang, Shengli Shen, Changwei Yuan, Yingjin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | International Journal of Genomics |
Online Access: | http://dx.doi.org/10.1155/2020/5069204 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mental Workload Analysis Using the NASA-TLX Method in the Engineering Department of PT ABC
by: Daniel Pardameian Simare Mare, et al.
Published: (2024-12-01) -
Identification of CDKN3 overexpression as a marker of poor prognosis and potential therapeutic target in low-grade glioma
by: Hongbing Cheng, et al.
Published: (2025-01-01) -
Comparative analysis of deep learning and radiomic signatures for overall survival prediction in recurrent high-grade glioma treated with immunotherapy
by: Qi Wan, et al.
Published: (2025-01-01) -
A deep ensemble learning framework for glioma segmentation and grading prediction
by: Liang Wen, et al.
Published: (2025-02-01) -
Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 glioma
by: Marshall Pitz, et al.
Published: (2025-02-01)